Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
<Evidence xmlns="http://hl7.org/fhir">
<id value="379725"/>
<meta>
<versionId value="4"/>
<lastUpdated value="2025-07-01T18:34:45.455Z"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Evidence 379725</b></p><a name="379725"> </a><a name="hc379725"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 4; Last updated: 2025-07-01 18:34:45+0000</p></div><p><b>ArtifactPublicationStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}">Active</span></p><p><b>url</b>: <a href="https://fevir.net/resources/Evidence/379725">https://fevir.net/resources/Evidence/379725</a></p><p><b>identifier</b>: FEvIR Object Identifier/379725</p><p><b>name</b>: Evidence_for_Results_for_Medication_Adherence_at_12_weeks_in_GroupAssignment_Quadpill_vs_Candesartan</p><p><b>title</b>: Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan</p><p><b>citeAs</b>: </p><div><p>Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 379725. Revised 2025-07-01. Available at: https://fevir.net/resources/Evidence/379725. Computable resource at: https://fevir.net/resources/Evidence/379725#json.</p>
</div><p><b>status</b>: Active</p><p><b>author</b>: Joanne Dehnbostel: </p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div><h3>RelatesTos</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Target[x]</b></td></tr><tr><td style="display: none">*</td><td>Part Of</td><td><a href="Composition-375280.html">Outcome Measure Report for QUARTET USA Trial</a></td></tr></table><p><b>description</b>: </p><div><p>This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>
</div><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href="EvidenceVariable-375183.html">GroupAssignment: Quadpill vs. Candesartan</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: <a href="EvidenceVariable-375201.html">Medication Adherence at 12 weeks</a></p></blockquote><blockquote><p><b>statistic</b></p><p><b>statisticType</b>: <span title="Codes:{https://fevir.net/sevco STATO:0000182}">odds ratio</span></p><p><b>quantity</b>: 0.63</p><p><b>numberOfEvents</b>: 0</p><p><b>numberAffected</b>: 41</p><h3>SampleSizes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>NumberOfParticipants</b></td><td><b>KnownDataCount</b></td></tr><tr><td style="display: none">*</td><td>62</td><td>53</td></tr></table><blockquote><p><b>attributeEstimate</b></p><p><b>type</b>: <span title="Codes:{https://fevir.net/sevco STATO:0000196}">confidence interval</span></p><p><b>level</b>: 0.95</p><p><b>range</b>: 0.19-2.08</p></blockquote><blockquote><p><b>attributeEstimate</b></p><p><b>type</b>: <span title="Codes:{https://fevir.net/sevco STATO:0000700}">p-value</span></p><p><b>quantity</b>: 0.444</p></blockquote></blockquote></div>
</text>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status">
<valueCodeableConcept>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
<code value="active"/>
<display value="Active"/>
</coding>
</valueCodeableConcept>
</extension>
<url value="https://fevir.net/resources/Evidence/379725"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net/FOI"/>
<value value="379725"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<name
value="Evidence_for_Results_for_Medication_Adherence_at_12_weeks_in_GroupAssignment_Quadpill_vs_Candesartan"/>
<title
value="Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"/>
<citeAs
value="Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 379725. Revised 2025-07-01. Available at: https://fevir.net/resources/Evidence/379725. Computable resource at: https://fevir.net/resources/Evidence/379725#json."/>
<status value="active"/>
<author>
<name value="Joanne Dehnbostel"/>
</author>
<publisher value="Computable Publishing LLC"/>
<contact>
<telecom>
<system value="email"/>
<value value="support@computablepublishing.com"/>
</telecom>
</contact>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<relatesTo>
<type value="part-of"/>
<targetReference>🔗
<reference value="Composition/375280"/>
<type value="Composition"/>
<display value="Outcome Measure Report for QUARTET USA Trial"/>
</targetReference>
</relatesTo>
<description
value="This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide."/>
<variableDefinition>
<variableRole value="population"/>
<observed>🔗
<reference value="EvidenceVariable/375183"/>
<type value="EvidenceVariable"/>
<display value="GroupAssignment: Quadpill vs. Candesartan"/>
</observed>
</variableDefinition>
<variableDefinition>
<variableRole value="outcome"/>
<observed>🔗
<reference value="EvidenceVariable/375201"/>
<type value="EvidenceVariable"/>
<display value="Medication Adherence at 12 weeks"/>
</observed>
</variableDefinition>
<statistic>
<statisticType>
<coding>
<system value="https://fevir.net/sevco"/>
<code value="STATO:0000182"/>
<display value="odds ratio"/>
</coding>
</statisticType>
<quantity>
<value value="0.63"/>
</quantity>
<numberOfEvents value="0"/>
<numberAffected value="41"/>
<sampleSize>
<numberOfParticipants value="62"/>
<knownDataCount value="53"/>
</sampleSize>
<attributeEstimate>
<type>
<coding>
<system value="https://fevir.net/sevco"/>
<code value="STATO:0000196"/>
<display value="confidence interval"/>
</coding>
</type>
<level value="0.95"/>
<range>
<low>
<value value="0.19"/>
</low>
<high>
<value value="2.08"/>
</high>
</range>
</attributeEstimate>
<attributeEstimate>
<type>
<coding>
<system value="https://fevir.net/sevco"/>
<code value="STATO:0000700"/>
<display value="p-value"/>
</coding>
</type>
<quantity>
<value value="0.444"/>
</quantity>
</attributeEstimate>
</statistic>
</Evidence>